Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-11-15
2010-11-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S342000, C514S365000, C514S438000, C514S567000, C544S162000, C546S269700, C548S204000, C549S077000, C562S469000
Reexamination Certificate
active
07834013
ABSTRACT:
The present invention relates generally to novel therapeutic compounds and more particularly to novel compounds, their use as GPR40 agonists, processes for their manufacture, and intermediates useful in their preparation.
REFERENCES:
patent: 5773644 (1998-06-01), Chen et al.
patent: WO02/057783 (2002-07-01), None
Vippagunta et al., Crystalline solids, 2001, Advanced Drug Delivery Reviews, 48, pp. 3-26.
Wolff et al., Burger's Medicinal Chemistry and Drug Discovery, 1994, Wiley-Interscience, Fifth Edition, vol. I: Principles and Practice, pp. 975-977.
Itoh et al., “Free fatty acids regulate insuling secretion from pancreatic beta cells through GPR40,” Nature, V422, N6928, pp. 173-176.
Corbett David Francis
Dwornik Kate Anna
Garrido Dulce Maria
McKeown Stephen Carl
Mills Wendy Yoon
Bianchi Kristin
Deppenbrock Bonnie L.
GlaxoSmithKline LLC
Saeed Kamal A
LandOfFree
Aminophenylcyclopropyl carboxylic acids and derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminophenylcyclopropyl carboxylic acids and derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminophenylcyclopropyl carboxylic acids and derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4237668